Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85701353 | 8570135 | 3 | F | 2012 | 20160722 | 20120521 | 20160727 | EXP | BR-AMGEN-BRASP2012030436 | AMGEN | 56.00 | YR | A | M | Y | 67.00000 | KG | 20160727 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85701353 | 8570135 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, ONCE WEEKLY | Y | 570892 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | ||||
| 85701353 | 8570135 | 2 | C | ATENOLOL. | ATENOLOL | 1 | 50 MG IF PRESSURE WAS STABLE/IF UNSTABLE: 100 MG | 0 | |||||||||||
| 85701353 | 8570135 | 3 | C | DAFLON /00426001/ | DIOSMIN | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 85701353 | 8570135 | 4 | C | DICLOFENAC SODIUM. | DICLOFENAC SODIUM | 1 | 100 MG, UNK | 0 | 100 | MG | |||||||||
| 85701353 | 8570135 | 5 | C | SULFASALAZINE. | SULFASALAZINE | 1 | 1000 MG, 2X/DAY | 0 | 1000 | MG | BID | ||||||||
| 85701353 | 8570135 | 6 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 1 TABLET, DAILY | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 85701353 | 8570135 | 1 | Ankylosing spondylitis |
| 85701353 | 8570135 | 2 | Hypertension |
| 85701353 | 8570135 | 3 | Peripheral vascular disorder |
| 85701353 | 8570135 | 4 | Ankylosing spondylitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 85701353 | 8570135 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 85701353 | 8570135 | Blood pressure decreased | |
| 85701353 | 8570135 | Blood pressure increased | |
| 85701353 | 8570135 | Chest discomfort | |
| 85701353 | 8570135 | Chills | |
| 85701353 | 8570135 | Depressed mood | |
| 85701353 | 8570135 | Dizziness | |
| 85701353 | 8570135 | Erythema | |
| 85701353 | 8570135 | Fatigue | |
| 85701353 | 8570135 | Feeling cold | |
| 85701353 | 8570135 | Hot flush | |
| 85701353 | 8570135 | Myalgia | |
| 85701353 | 8570135 | Pallor | |
| 85701353 | 8570135 | Poisoning | |
| 85701353 | 8570135 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 85701353 | 8570135 | 1 | 20120405 | 2012 | 0 | |
| 85701353 | 8570135 | 2 | 1991 | 0 | ||
| 85701353 | 8570135 | 3 | 2003 | 0 | ||
| 85701353 | 8570135 | 4 | 1996 | 0 |